Another blood pressure medication recalled over cancer risk

Macleods Pharmaceuticals has recalled one lot of the blood pressure medication Losartan after discovering trace amounts of a cancer-causing impurity in the product.

The tablets may contain N-nitrosodiethylamine, a probable human carcinogen.

The active drug ingredient was made at Hetero Labs in India, one of two drug manufacturers linked to a string of blood pressure medication recalls.

Macleods is the latest drugmaker to recall the blood pressure drug amid heightened safety concerns over the detection of the cancer-causing impurity. Major Pharmaceuticals, Teva Pharmaceuticals, Mylan and Aurobindo Pharma have also recalled blood pressure drugs in the last year.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars